GLY145ARG mutation emerging under HBIG treatment in patients with recurrent HBV after liver transplantation strongly reduces viral secretion

Transplant Proc. 2001 Nov-Dec;33(7-8):3633-6. doi: 10.1016/s0041-1345(01)02563-5.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Arginine
  • Bacterial Proteins*
  • Carcinoma, Hepatocellular
  • DNA-Binding Proteins / analysis
  • Genome, Viral
  • Glycine
  • Hepatitis B / genetics*
  • Hepatitis B / surgery*
  • Hepatitis B virus / genetics*
  • Hepatitis B virus / isolation & purification
  • Humans
  • Immunization, Passive
  • Immunoglobulins / therapeutic use*
  • Liver Neoplasms
  • Male
  • Middle Aged
  • Mutation*
  • Peptide Fragments / analysis
  • Recurrence
  • Ribonucleases / analysis
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Bacterial Proteins
  • DNA-Binding Proteins
  • Immunoglobulins
  • L-protein, Peptococcus magnus
  • Peptide Fragments
  • ribonuclease S-peptide
  • Arginine
  • Ribonucleases
  • Glycine
  • hepatitis B hyperimmune globulin